Advanced gastric cancer Cancer Stomach, unspecified
Conditions
Interventions
All patients with advanced GC treated by FP regimen (Tegafur + Cisplatin) in Zhangqiu People's Hospital of Shandong were enrolled for this clinical study by a doctor participating in the study and ra
Sponsors
Zhangqiu People's Hospital of Shandong
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age from 25 to 75 years 2. All patients were pathologically confirmed for stage IV or postoperative recurrence and metastasis GC 3. Karnofsky performance score (KPS) = 80 4. No previous anticancer therapy 5. No dysfunction of heart, liver, lung and kidney
Exclusion criteria
Exclusion criteria: 1. Age75 years 2. Patients were not pathologically confirmed for stage IV or postoperative recurrence and metastasis GC 3. Karnofsky performance score (KPS) < 80 4. Possess previous anticancer therapy 5. Possess dysfunction of heart, liver, lung and kidney
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at week 9 (after 3 cycles of chemotherapy): 1. Appetite, assessed by filling out answer sheets 2. Karnofsky performance score (KPS), assessed by filling out answer sheets 3. Body weight, measured using a weight scale | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-year overall survival: patients followed up by clinic visit, phone, or mail at least once every 6 months starting from day 1 after the treatment | — |
Countries
China
Outcome results
None listed